# LIFYORLI (COPACKAGED)
> **NDA220641** · New Drug Application · Sponsor: CORCEPT THERAP · Approved 2026-03-25
## Drug
- **FDA Application Number:** NDA220641
- **Application type:** New Drug Application
- **Brand name:** LIFYORLI (COPACKAGED)
- **Generic name:** RELACORILANT
- **Active ingredients:** RELACORILANT
- **Dosage form:** CAPSULE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** CORCEPT THERAP
- **Manufacturer:** Corcept Therapeutics Incorporated
- **First approval:** 2026-03-25
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=220641)
---
*MORVS · CC0 1.0*